MHRA Safety Guidelines for Pregnant Women
Aciclovir Safety During Pregnancy
The Medicines and Healthcare products Regulatory Agency (MHRA) classifies aciclovir as generally safe for use during pregnancy when clinically necessary. Extensive safety data shows no increased risk of birth defects when aciclovir is used appropriately. The medication crosses the placenta in limited amounts, and studies involving thousands of pregnancies have not identified any pattern of congenital abnormalities.
When Aciclovir May Be Prescribed
Healthcare professionals may recommend aciclovir during pregnancy for several scenarios. Severe or frequent cold sore outbreaks that significantly impact quality of life may warrant oral aciclovir treatment. Primary herpes infections during pregnancy, which can be more serious than recurrent episodes, often require antiviral therapy. Additionally, women with a history of frequent outbreaks may be prescribed suppressive therapy, particularly in the third trimester.
Treatment Options Available
EverydayMeds offers several aciclovir formulations suitable for pregnant women under medical supervision. Aciclovir 400mg tablets provide systemic treatment for severe outbreaks or suppressive therapy. Topical aciclovir 5% cream offers localised treatment with minimal systemic absorption, making it often the preferred first-line option. Valaciclovir tablets, which convert to aciclovir in the body, may sometimes be prescribed as an alternative with similar safety profiles during pregnancy.
Dosage and Administration Guidelines
Dosing during pregnancy follows standard protocols but requires medical supervision. For episodic treatment of cold sores, aciclovir 400mg is typically taken three times daily for five days, starting as early as possible when symptoms begin. Suppressive therapy, if recommended, usually involves lower daily doses. Topical cream should be applied five times daily to affected areas, continuing for several days after healing begins.
Breastfeeding Considerations
Aciclovir is considered compatible with breastfeeding, as only small amounts pass into breast milk. The levels detected are well below therapeutic doses given directly to infants. Most healthcare professionals agree that the benefits of treating maternal cold sores outweigh any minimal risks to the nursing infant. However, mothers should avoid direct contact between cold sores and their baby's skin or mouth during feeding.
